All Business articles – Page 32
-
BusinessBayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
BusinessAtanor chemical plant in Argentina shuttered
Toxic releases have led to the indefinite closure of the facility after a decade-long legal fight
-
BusinessBrexit could push Japanese pharma out of the UK
Warnings that Japanese R&D investment in the UK is endangered by plans to leave the EU
-
BusinessSadara cracker eyes richer chemical rewards
Joint venture between Dow and Saudi Aramco will target added value plastics and speciality chemicals
-
BusinessHealthcare firms invest in Crispr gene editing technology
Crispr licence agreements open up opportunities in drug discovery
-
BusinessNovartis reshuffle puts 120 staff at risk
Commitment to gene and cell therapy treatments emphasised as unit broken up amid pharmaceutical division refocus
-
BusinessUS government agency awards Monsanto whistleblower $22 million
Pay-out is second largest reward from US whistleblower programme
-
BusinessJoined-up thinking
The rift between contract medicinal chemistry and chemical development needs to be bridged
-
BusinessFatal incidents at two chemical plants
In recent weeks three people have been killed in chemical plant accidents in Malaysia and the US
-
BusinessFDA urges labs to test all blood donations for Zika
Agency has also given emergency authorisation to two new Zika blood tests
-
BusinessPfizer to buy Astrazeneca’s antibiotics
Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
-
BusinessPfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
BusinessEU examines Dow–DuPont union
European commission probes competition implications of the planned mega-merger
-
BusinessOn the innovation horizon
Bringing disruptive technology to market requires enhanced collaboration
-
BusinessUS government sued over merger crackdown
Business groups challenge Obama’s steps to limit tax inversions
-
BusinessRohm and Haas fined for safety violations
Fines relate to a trimethylaluminium explosion that injured four in January
-
BusinessStandard antibody will bolster biopharma
New NIST reference material will help validate and compare analytical techniques
-
BusinessAmgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
BusinessJob cuts at Takeda, Boehringer and Arena
Hundreds of positions eliminated as companies re-evaluate R&D
-
BusinessFibrant to quit US operations
Caprolactam supplier will shed hundreds of jobs, while operations in Europe and China continue